Estimating the Economic Burden of Hypoglycemia in Patients with Type 1 and Type 2 Diabetes Mellitus in Austria

Abstract

A 3 4 7 -A 7 6 6 on the comparison between expenditures of the diabetic and non-diabetic populations. Then, we observe over 8 years the dynamics of the costs attributable to diabetes. Results: We identify 220,000 persons who were newly treated for type 2 diabetes in 2008 (45 years and older). This provides an incidence rate of 1,160 per 100,000 insured persons. Among people with newly treated diabetes, 52% are men. The mean age is 64 years (62 years for men and 65 years for women). Based on this cohort, we aim to assess the change over time of overall cost and costs attributable to diabetes due to the natural history of the disease. ConClusions: Describing the impact of the natural history of the disease on the cost of type 2 diabetes on such a large cohort of patients will give policy maker a better understanding of how diabetes, its complications and health care affect expenditures over time.